CDT Equity Inc. — Form 8-K/A
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 78/100
What the filing says
On February 19, 2026, CDT Equity Inc. acquired 20% of Sarborg Limited (1,020 shares) from its shareholders for: 2,392 CDT common shares, pre-funded warrants for 439,915 CDT shares, and $8 million in deferred cash (due when CDT raises ≥$20M via ATM). CDT accounts for this as an equity-method investment. Sarborg is a 16-month-old AI/pharmaceutical discovery company with $4.6M revenue (2025), $0.8M accumulated deficit, $10K cash, and substantial going-concern doubt; 100% of its revenue came from CDT under multiple service agreements. Pro forma adjusts CDT's equity by +$115M (stock/warrants) and adds $8M accrued liability.
Why this rating
Deal is significant for CDT (≈$55K market cap): it adds $115M equity value and $8M contingent liability at 1,800x+ relative size. However, Sarborg's revenue concentration risk (100% from CDT), going-concern flag, and pre-money valuation (~$40M at 20% stake) are severe. CDT stock issuance is highly dilutive. Deal materially changes CDT's balance sheet and control but Sarborg's viability remains unproven.
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.